WHAT IS CAGRILINTIDE Cagrilintide is a synthetic, long-acting amylin analog peptide developed by Novo Nordisk as a potential treatment for obesity and related metabolic conditions
10.1016/j.cell.2020.12.028 30 ChangX.DorajooR.SunY.WangL.OngC
Three additional patients with an A at position 243 had a C at position 248 (C only in two of them, a mixture of C and T in one)
By focusing on metabolic pathways at the cellular level, it provides an advanced method for improving athletic performance, decreasing fat accumulation, and maybe prolonging lifespan
Accin en las clulas pancreticas e intestino En las clulas pancreticas, la activacin del GLP-1R incrementa la exocitosis de grnulos de insulina , mejora la expresin de genes implicados en la funcin secretora y promueve mecanismos de supervivencia celular, contribuyendo a la preservacin de la masa funcional de dichas clulas (3)
Gradual improvement in skin tone and overall skin health